Lepu MedTech's GuiTracker® High-Support Guidewire Receives Market Approval in China
Shape Memory Alloy
Structural Heart Disease Medical Product R&D and Manufacturer
Heart Future
Recently,Shanghai Shape Memory Alloy Co.,Ltd.（MicroPort CardioFlow Medtech CorporationWholly-owned subsidiary) independently developed byGuiTracker® Hard GuidewireApproved for marketing by the Shanghai Municipal Medical Products Administration (Registration Certificate No.: Hu Medical Device Registration Approval 20252030423).
The launch of this product marks a significant milestone for Shanghai Shape Memory Alloy Co., Ltd. in"Device + Access"Another key breakthrough in the innovation system also means that domestically produced interventional medical devices have achieved a new leap in the field of high-support guidewires.
GuiTracker® Hard guidewires are mainly applied inCardiovascular and Peripheral Vascular Interventional SurgeryShape Memory Alloy, used forGuide other instruments into the blood vessel and establish a percutaneous access., which is a fundamental tool for interventional treatments such as heart valve implantation, occluder release, and stent delivery.
For a long time, guidewires have been regarded as“The Lifeline of Interventional Treatment”, whose performance stability directly determines whether the subsequent instrument can successfully reach the target lesion location.
In complex vascular lesions, such as severely tortuous or calcified vessels, traditional guidewires often suffer from insufficient support and weak pushability.“Beyond One's Power”, which can easily lead to difficulties in positioning the instruments or even surgical failure.GuiTracker® The birth of this product is precisely aimed at this clinical pain point, providing a solution that combines bothSolutions with high support, flexible control, and excellent visibility。
# Core Technology Highlights
——Four Major Performance Breakthroughs, Reshaping the "Access Experience" in Intervention
GuiTracker® The development of hard guidewires reflects Cardial Medical'sSystematic Innovation in the Field of Guide Wire Material Science and Structural Design。
It is not just“Stiffer guidewire”, but through the synergistic optimization of materials, processes, and coatings, it provides unprecedented pathway stability and operational smoothness for complex cardiovascular interventions.
1. Strong Support: High-Strength Stainless Steel Core Wire Builds Stability"Track"
GuiTracker® The core lies in itsHigh Support。
The high-strength stainless steel core wire built into the guidewire provides excellent resistance to bending, maintaining controllable deformation and being less prone to collapse, even in severely tortuous vascular structures.
This stable“Skeleton Support”Allow subsequent interventional devices such as valves, occluders, and stents to be advanced smoothly along the guidewire, greatly reducing the difficulty during surgery.“Instrument Jamming”Or“Offset”The risk.
In other words, it provides the operator with assistance in complex vasculature.“Built a solid highway”, significantly improving the success rate of surgery.
2. Precise Imaging: Gold+ Stainless steel double-layer spring, clearly presents the head-end shape
Guidewire“Eyes”Equally crucial.GuiTracker® AdoptInner Layer Gold + Outer Layer Stainless SteelThe Dual-Spring Composite Structure Design，The high visibility of gold makes the guidewire tip clearly visible under fluoroscopy, allowing doctors to accurately assess the guidewire's position, angle, and shape during the procedure.
This precise imaging design not only enhances operational safety but also provides doctors with a stronger sense of spatial awareness and directional judgment in complex lesion areas.
3. Flexible shaping: Stainless steel spring structure, adaptable to diverse cardiac anatomies
GuiTracker® The outer layer stainless steel spring structure has good plasticity. DoctorThe tip of the guidewire can be fine-tuned at any time as needed during the surgery., allowing it to adapt to the cardiac and vascular anatomical morphology of different patients.
This“As You Wish”The plasticity avoids the risk of vascular wall injury or misentry into branches due to mismatched guidewire shapes, especially inCongenital Heart Disease (CHD) and Valve Replacement SurgeryOf great significance in China.
4. Smooth and Stable: Hydrophobic Coating Enhances Operation"Slippery but not脱落"
The surface of the guidewire adoptsSpecialHydrophobic Coating, with extremely low push resistance，Can smoothly navigate through tortuous vessels, significantly reducing the coefficient of friction.
More importantly,GuiTracker® In“In place”Afterward, it can provide sufficient adhesion without slipping or shifting.It ensures both the smoothness of the propulsion process and the stable support during positioning.
This“Slippery but not脱落”The dual performance represents an extremely rare balance point in guidewire design. It enables doctors to maintain precise control of the instrument over long distances and through complex pathways, enhancing operational confidence and efficiency.
# Clinical Significance and Product Ecosystem
——From "Single Guidewire" to "Device + Access" System
GuiTracker® The approval of the hard guidewire represents not only the launch of a single product but also stands for the advancement of Cardial Medical inSystematic Innovation in Interventional Pathways for Structural Heart DiseaseA key landing on.
In interventional surgery, although the guidewire is small in size, it isAll percutaneous treatments“First Entrance”And“Core Pathway”——It determines whether high-value devices such as occluders, valves, and stents can reach the lesion site accurately and safely.
1. Complex Lesions"Building Bridges and Roads": Improving Surgical Success Rates and Safety
On the clinical front line, doctors often describe high-difficulty interventional surgeries as“Feeling One's Way Through a Narrow Vessel”。
GuiTracker® The emergence of Shape Memory Alloy makes this process more like“Precision Bridging, Smooth Passage”——With itsHigh support, non-slip, precise imaging, and smooth maneuverability, providing a stable access for complex blood vessels, significantly improving the success rate of surgery and safety during the operation.
Its application scenarios are not limited to routine coronary or peripheral vascular interventions, but also cover:
Congenital Heart Disease (e.g.PFO、ASDOcclusion)
Valve interventional surgery (e.g.TAVR、TMVR）
Complex vascular surgeries such as peripheral artery stenosis and iliac-femoral lesions
In these high-risk surgeries,GuiTracker® ProvidedHigh Pushability and Precise Guidance Capability, which can help the surgeon achieve precise instrument deployment in complex anatomical environments, thereby ensuring surgical controllability and long-term efficacy.
2. Strategic Positioning: Xintai Medical"The Key Puzzle of the 'Device + Access' Ecosystem"
GuiTracker® The approval and market launch is a milestone for XinTai Medical.“Instrument+Access”An important part of the product ecosystem layout.
In this strategy, Xintai not only focuses on core interventional devices for structural heart disease (such as valves and occluders) but also simultaneously builds systematic solutions around safety and efficiency during surgical access.
This systematic layout helps to:
Enhance Instrument Synergy Performance——Guidewires, delivery systems, occluders, and other products can form a complementary optimization;
Build a Sustainable Innovation Platform——Establish technical barriers in the field of access devices;
Strengthen Comprehensive Clinical Competitiveness——From“Single Product”Turn to“Complete Solution”Provider.
GuiTracker® The advent of this product means that Cardial Medical is moving from single-point innovation to systematic innovation, from“Product Manufacturer”Trend“Interventional Ecology Leader”。
# Industry Perspective and Future Outlook
——The Rise of Chinese-Made Guide Wires and Their Globalization Potential
GuiTracker® The launch of the hard guidewire representsChina-produced High-end Interventional Guidewire TechnologyIs gradually moving away from“Follower”Trend“Leader”。
In the past global market landscape, the guidewire field has long been dominated by overseas giants (such asTerumo、Boston Scientific、Abbott、Asahi) monopolized, Chinese enterprises face significant technical barriers in guidewires with high support and high pushability.
GuiTracker® The launch marks the milestone for enterprises in China.Material Development, Mechanical Property Design, Visualization Accuracyin key dimensions, achieving independent breakthroughs, and also injecting new momentum into the autonomous and controllable intervention industry chain in China.
1. Technical Breakthrough: Let“Chinese-made guidewire”From Available to“CanU”
Although small, the guidewire is one of the most critical components in interventional treatment systems and highly tests manufacturing craftsmanship.
GuiTracker® Innovations in materials and processes have enabled domestically produced guidewires to achieve performance metrics comparable to international high-end products for the first time:
High Support Force：Can address complex lesions in large vessels such as the aortic valve and iliac-femoral arteries;
High Visibility Precision：Significant improvement in the clarity of gold composite imaging;
High Pushability and Stability：Maintains a stable passage even in extremely tortuous vessels;
Low Friction Resistance：Special hydrophobic coating ensures smooth and fluent operation.
This means that the guidewires produced in China are no longer just“Substitute”, and began to become clinically relevant“Preferred Option”, especially against the backdrop of the rapid development of domestically produced interventional devices for structural heart disease, the synergy and complementary value of its industrial chain have become increasingly prominent.
2. Domestic Ecosystem Collaboration: Building"The Systemic Competitiveness of the Chinese Solution"
XinTai Medical, backed by the Lepu Group, has formed a comprehensive chain in the cardiovascular intervention industry from...Material—Guidewire—Delivery System—Occlusion/Valve Instruments—Imaging AssistanceThe complete closed loop.
GuiTracker® The approval further perfected this ecosystem, making“Chinese Production Solution”In the treatment of structural heart disease, it hasFull-process autonomous and controllable capabilities。
This systematic innovation not only enhances the safety and efficiency of surgeries but also reduces overall treatment costs, strengthening the comprehensive competitiveness of China's interventional medical devices in the international market.
In the future,GuiTracker® It is expected to form a complementary output with the self-developed valve and occlusion systems by Shanghai Shape Memory Alloy Co., Ltd. (LePu Cardiovascular), achieving synergistic growth in international registration and overseas clinical promotion, and providing a strong boost.“Made in China”Go Global.
3. Future Outlook: Continuous Innovation Centered on Clinical Needs
From early structural heart disease treatment devices to today's innovative access products, every breakthrough by Xintai Medical is driving China's interventional treatment field forward.“Safer, More Accurate, More Systematic”The direction of evolution.
GuiTracker® The successful approval of the hard guidewire not only represents a progress in domestically produced guidewire technology, but also epitomizes China's medical device industry advancing towards high-end manufacturing and global competition.
It allows“Complex Lesion Interventions: From Groping in the Dark to Precise Bridge Building”`, also allowing domestic innovation to truly begin.`“Leading the Way in Surgery”。
# Heart Future · Observation
GuiTracker® The emergence marks another leap in the innovation system of guidewires produced in China.
It allows us to see that in the rapid evolution of global cardiovascular interventional technology, Chinese enterprises are not only catching up but also forging their own path of innovation.
In the future, with“Instrument+Access”The continuous improvement of the ecosystem and the breakthrough of a guidewire might just be the starting point of a new chapter in China's precision medicine.
GCC2025
Full-spectrum Cardiovascular Device Solutions
Statement
Content Declaration:"Future of the Heart" tracks global medical technology advancements, aiming to disseminate technical and industry knowledge. All content is for professional exchange and academic discussion only, and does not constitute medical advice or commercial promotion. Information about companies, products, and registrations mentioned in the text is sourced from publicly available materials or verified channels. If there are any errors or omissions, please contact us for corrections. Email: jacky@suribot.com
Copyright Statement:The original article "Heart of the Future" is copyrighted by Beijing Siyu Bot Technology Co., Ltd. Unauthorized reproduction, excerpting, or mirroring on other websites, official accounts, or commercial platforms is prohibited; for authorized reproduction, please contact the backend to obtain permission. This platform reserves the right to pursue legal responsibility for unauthorized full-text reproduction, rewriting, or paraphrasing.
